This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
ORANGEBURG, N.Y., March 17, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, is pleased to announce that Cheryl Pegus, M.D., President of Caluent, Director and Strategic Advisor of Glytec, and the Lead Independent Director of Vision-Sciences, will appear on a segment of the Bloomberg News TV show "Taking Stock with Pimm Fox" on Wednesday, March 19, 2014 during the 5:00 – 6:00 PM EDT hour.
"We are thrilled that Dr. Pegus will have the opportunity to discuss Vision Sciences' innovative Endosheath technology on
Taking Stock with Pimm Fox," said Lewis C. Pell, Chairman and Co-founder of Vision-Sciences. "Our technology has become even more relevant in light of the recent focus on hospital-acquired infections and the steps the healthcare industry needs to take to help prevent these infections from developing."
Vision-Sciences' patented and FDA-cleared EndoSheath technology is the only flexible endoscopic technology on the market with a sterile, single-use barrier which prevents direct contact with the patient and reduces the difficulties of providing a sterile, patient ready device. In 20 years and with over 5 million procedures performed with EndoSheath technology, Vision-Sciences has never received a report of patient-to-patient cross-contamination.
Date: Wednesday, March 19, 2014
Time: 5:00 – 6:00 PM EDT
Outlet: Bloomberg News TV "Taking Stock with Pimm Fox"
For more information call Mitch Kayden at 845-709-5607 or email at
About Vision-Sciences, Inc.
Vision-Sciences, Inc. designs, develops, manufactures and markets products for flexible endoscopy. The Company's unique product lines feature a streamlined visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath
® technology, providing users with efficient and cost effective endoscope turnover while enhancing patient safety. Information about Vision-Sciences' products is available at
Vision-Sciences owns the trademark Vision Sciences™ and the registered trademarks EndoSheath
®, and The Vision System
CONTACT: Mitch Kayden
Sr. Media Strategist
Onit Digital Marketing
Keith J. C. Darragh